PortfoliosLab logo
LMAT vs. ZBH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LMAT and ZBH is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

LMAT vs. ZBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

LMAT:

0.19

ZBH:

-0.81

Sortino Ratio

LMAT:

0.48

ZBH:

-0.93

Omega Ratio

LMAT:

1.07

ZBH:

0.86

Calmar Ratio

LMAT:

0.24

ZBH:

-0.45

Martin Ratio

LMAT:

0.59

ZBH:

-1.82

Ulcer Index

LMAT:

11.23%

ZBH:

11.51%

Daily Std Dev

LMAT:

34.60%

ZBH:

25.99%

Max Drawdown

LMAT:

-75.69%

ZBH:

-65.03%

Current Drawdown

LMAT:

-25.48%

ZBH:

-43.28%

Fundamentals

Market Cap

LMAT:

$1.81B

ZBH:

$18.84B

EPS

LMAT:

$1.97

ZBH:

$4.50

PE Ratio

LMAT:

40.74

ZBH:

21.16

PEG Ratio

LMAT:

2.14

ZBH:

1.23

PS Ratio

LMAT:

8.01

ZBH:

2.45

PB Ratio

LMAT:

5.30

ZBH:

1.52

Total Revenue (TTM)

LMAT:

$226.26M

ZBH:

$7.70B

Gross Profit (TTM)

LMAT:

$154.18M

ZBH:

$5.11B

EBITDA (TTM)

LMAT:

$65.12M

ZBH:

$1.79B

Returns By Period

In the year-to-date period, LMAT achieves a -12.68% return, which is significantly lower than ZBH's -9.67% return. Over the past 10 years, LMAT has outperformed ZBH with an annualized return of 24.28%, while ZBH has yielded a comparatively lower -0.53% annualized return.


LMAT

YTD

-12.68%

1M

-1.35%

6M

-22.70%

1Y

6.27%

5Y*

26.20%

10Y*

24.28%

ZBH

YTD

-9.67%

1M

-6.89%

6M

-11.60%

1Y

-20.82%

5Y*

-2.88%

10Y*

-0.53%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LMAT vs. ZBH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LMAT
The Risk-Adjusted Performance Rank of LMAT is 5757
Overall Rank
The Sharpe Ratio Rank of LMAT is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of LMAT is 5151
Sortino Ratio Rank
The Omega Ratio Rank of LMAT is 5151
Omega Ratio Rank
The Calmar Ratio Rank of LMAT is 6363
Calmar Ratio Rank
The Martin Ratio Rank of LMAT is 5959
Martin Ratio Rank

ZBH
The Risk-Adjusted Performance Rank of ZBH is 1212
Overall Rank
The Sharpe Ratio Rank of ZBH is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of ZBH is 1414
Sortino Ratio Rank
The Omega Ratio Rank of ZBH is 1212
Omega Ratio Rank
The Calmar Ratio Rank of ZBH is 2323
Calmar Ratio Rank
The Martin Ratio Rank of ZBH is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LMAT vs. ZBH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current LMAT Sharpe Ratio is 0.19, which is higher than the ZBH Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of LMAT and ZBH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

LMAT vs. ZBH - Dividend Comparison

LMAT's dividend yield for the trailing twelve months is around 0.85%, less than ZBH's 1.01% yield.


TTM20242023202220212020201920182017201620152014
LMAT
LeMaitre Vascular, Inc.
0.85%0.69%0.99%1.09%0.88%0.94%0.95%1.18%0.69%0.71%0.93%1.83%
ZBH
Zimmer Biomet Holdings, Inc.
1.01%0.91%0.79%0.75%0.76%0.62%0.64%0.93%0.80%0.93%0.86%0.78%

Drawdowns

LMAT vs. ZBH - Drawdown Comparison

The maximum LMAT drawdown since its inception was -75.69%, which is greater than ZBH's maximum drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for LMAT and ZBH. For additional features, visit the drawdowns tool.


Loading data...

Volatility

LMAT vs. ZBH - Volatility Comparison

LeMaitre Vascular, Inc. (LMAT) has a higher volatility of 16.18% compared to Zimmer Biomet Holdings, Inc. (ZBH) at 14.47%. This indicates that LMAT's price experiences larger fluctuations and is considered to be riskier than ZBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

LMAT vs. ZBH - Financials Comparison

This section allows you to compare key financial metrics between LeMaitre Vascular, Inc. and Zimmer Biomet Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20212022202320242025
59.87M
1.91B
(LMAT) Total Revenue
(ZBH) Total Revenue
Values in USD except per share items

LMAT vs. ZBH - Profitability Comparison

The chart below illustrates the profitability comparison between LeMaitre Vascular, Inc. and Zimmer Biomet Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%62.0%64.0%66.0%68.0%70.0%72.0%20212022202320242025
69.2%
63.3%
(LMAT) Gross Margin
(ZBH) Gross Margin
LMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, LeMaitre Vascular, Inc. reported a gross profit of 41.42M and revenue of 59.87M. Therefore, the gross margin over that period was 69.2%.

ZBH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.21B and revenue of 1.91B. Therefore, the gross margin over that period was 63.3%.

LMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, LeMaitre Vascular, Inc. reported an operating income of 12.63M and revenue of 59.87M, resulting in an operating margin of 21.1%.

ZBH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported an operating income of 338.90M and revenue of 1.91B, resulting in an operating margin of 17.8%.

LMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, LeMaitre Vascular, Inc. reported a net income of 11.01M and revenue of 59.87M, resulting in a net margin of 18.4%.

ZBH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a net income of 182.00M and revenue of 1.91B, resulting in a net margin of 9.5%.